Liujia learned pharmacology in Tongji Medical School, Huazhong University of Science and Technology (2012-2016), and acquired her master degree in China State Institute of Pharmaceutical Industry (2016-2019). She joined the Guomics team in 2019 as a visiting student with a main research focus in proteome rhythm. She then became a PhD candidate in the same year. Liujia received her Ph.D. degree at Westlake University in March 2023, and now she is a postdoctoral researcher for proteomic big data research.
1.Nie, X.#, Qian, L. #, Sun, R. #, Huang, B. #, Dong, X. #, Xiao, Q. #, Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021). Multi-organ proteomic landscape of COVID-19 autopsies. Cell 184, 775-791 e714. (#, co-first author)
2.Qian, L., and Guo, T. (2021). Immunometabolism the CyTOF way. Immunity 54, 610-613.
3.Luo, X. #, Qian, L. #, Xiao, Y., Tang, Y., Zhao, Y., Wang, X., Gu, L., Lei, Z., Bao, J., Wu, J., et al. (2019). A diversity-oriented rhodamine library for wide-spectrum bactericidal agents with low inducible resistance against resistant pathogens. Nat Commun 10, 258. (#, co-first author)
4.Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian, L., et al. (2020). Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 182, 59-72 e15.